A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

Summary

A clinical study to evaluate the long-term safety and tolerability of an investigational drug in people with schizophrenia. This study is accepting male and female participants between 18 years old -65 years old who have been diagnosed with schizophrenia. This study will be conducted in approximately 50 study centers worldwide. The study will last approximately 57 weeks.

Timeline

Start

2019-11-21

Primary completion

2022-12-30

Completion

2022-12-30

Drugs

Indications